
Evogene Ltd. EVGN
€ 0.64
-0.31%
Geschäftsbericht 2025
hinzugefügt 25.04.2026
Evogene Ltd. P/S 2011-2026 | EVGN
P/S Jährlich Evogene Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 71.3 | 127 | 52 | 29.2 | 23.3 | 19.3 | 15.1 | 14.5 | 19.4 | 5.57 | 4.85 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 127 | 4.85 | 34.7 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
172 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
0.429 | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.73 | $ 16.89 | -2.37 % | $ 789 M | ||
|
AgeX Therapeutics
AGE
|
9.24 | - | -10.17 % | $ 12.2 K | ||
|
Compugen Ltd.
CGEN
|
49.8 | $ 2.85 | -5.94 % | $ 266 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Coherus BioSciences
CHRS
|
5.36 | $ 1.58 | -3.37 % | $ 185 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
2.13 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
2.65 | $ 7.46 | -4.73 % | $ 204 M | ||
|
Eton Pharmaceuticals
ETON
|
6.99 | $ 29.73 | -0.77 % | $ 800 M | ||
|
Exelixis
EXEL
|
5.05 | $ 50.09 | -1.98 % | $ 13.6 B | ||
|
Midatech Pharma plc
MTP
|
240 | - | -18.52 % | $ 27.3 M | ||
|
Fortress Biotech
FBIO
|
1.23 | $ 2.47 | 7.39 % | $ 68.9 M | ||
|
Forte Biosciences
FBRX
|
181 | $ 22.53 | -5.97 % | $ 292 M | ||
|
Fennec Pharmaceuticals
FENC
|
3.78 | $ 9.51 | 2.92 % | $ 272 M | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 4.03 | -8.52 % | $ 1.2 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.57 | -1.26 % | $ 418 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
BioNTech SE
BNTX
|
35.7 | $ 88.94 | -3.32 % | $ 21.5 B | ||
|
Gilead Sciences
GILD
|
6.23 | $ 129.56 | -1.9 % | $ 161 B | ||
|
Genmab A/S
GMAB
|
15.6 | $ 26.79 | -0.41 % | $ 1.73 B | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
11.9 | $ 3.36 | -5.62 % | $ 5.53 M | ||
|
Aeterna Zentaris
AEZS
|
1.54 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Grifols, S.A.
GRFS
|
0.627 | $ 7.67 | -1.6 % | $ 5.21 B | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Esperion Therapeutics
ESPR
|
1.39 | $ 3.13 | 0.32 % | $ 651 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 21.66 | 0.42 % | $ 2.76 B |